-
Upfront management of brain metastases in oncogene‑addicted NSCLC – An EORTC survey
Ortega-Franco, A., Houda, I., Brandão, M., Pierret, T., Käsmann, L., Giaj-Levra, N., Remon, J., Berghmans, T., Dingemans, A.-M. C., Faivre-Finn, C. & Hendriks, L. E. L., 1 Jul 2026, In: Lung Cancer. 217, 109444.Research output: Contribution to journal › Article › Academic › peer-review
-
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial
Ulas, E. B., Purcell, N. D., Houda, I., Hashemi, S. M. S., Veltman, J., Daniels, J. M. A., Fransen, M. F., Radonic, T., Beeloo, L. R., van Rossum, P. S. N., van Maldegem, F., Barlo, N., Disselhorst, M., van Laren, M., Tiemessen, M. A., Tarasevych, S., van Haarst, J. M., van Tilburg, P., Kunst, P. W. A. & Moons-Pasic, A. & 7 others, , 22 Jun 2026, In: Journal for Immunotherapy of Cancer. 14, 6Research output: Contribution to journal › Article › Academic › peer-review
-
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC
Ulas, E. B., Koomen, S. J. I., Vrijmoet, A., Houda, I., Korkmaz, H. I., Dickhoff, C., Bahce, I., Senan, S., de Gruijl, T. D., Fransen, M. F., Radonic, T., van Maldegem, F. & Schneiders, F. L., 28 Nov 2025, In: Journal for Immunotherapy of Cancer. 13, 11, e013237.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
